Cargando...
The potential effects of clinical antidiabetic agents on SARS‐CoV‐2
BACKGROUND: Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2), is currently posing significant threats to public health worldwide. It is notable that a substantial proportion of patients with sever COVID‐19 have coexisting diabetic conditions...
Gardado en:
| Publicado en: | J Diabetes |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wiley Publishing Asia Pty Ltd
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7753367/ https://ncbi.nlm.nih.gov/pubmed/33210826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1753-0407.13135 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|